Pharma giant Moderna and its partner Merck said on Wednesday (July 26) that they had begun taking in patients for a late-stage study testing their personalised skin cancer vaccine in combination with immunotherapy Keytruda.

Moderna/Merck kick off late-stage study of skin cancer vaccine

A French court has ordered a formal investigation of German pharmaceutical firm Merck for failing to inform patients about the side effects of its thyroid drug, Levothyrox.

French court charges German pharma firm Merck with ‘deceit’ over thyroid drug

The antiviral pill molnupiravir reduced the risk of COVID-19 hospitalisation by 65% in a new study by Indian researchers that offered stronger results than previous research about the drug’s effectiveness.

A Covid pill from Merck showed more promise in reducing the risk of hospitalisation

French health minister said on Wednesday that France had cancelled its order of Merck & Co's Covid antiviral drug. This step was taken after the trail data showed disappointing results.

Jolt for Merck as France cancels order for Covid antiviral drug

The European Medical Agency on Thursday gave go-ahead for emergency use of Pfizer's Covid pill. Formal approval is still pending. The initial go-ahead has been given to curb Omicron infection.

EU drug regulator gives go-ahead for Pfizer Covid pill's emergency use

US Food and Drug Administration approved molnupiravir, an anti-Covid pill developed by Merck, as effective against the deadly virus. However, the recent analysis shows a lower efficacy rate than a previous estimate.

New analysis reveals Merck's Covid-19 pill, Molnupiravir, has lower efficacy

US drugmaker Merck & Co. on Wednesday announced a deal that could see generic versions of its medication for Covid sufferers widely distributed in poorer countries, in a first during the pandemic.

Merck strikes deal for global access to Covid drug

US drugmaker Merck applied for emergency use authorisation in the United States for its pill to fight against coronavirus. The company had claimed that molnupiravir reduced hospitalisations by 50 per cent.

Merck seeks US FDA's authorisation for COVID-19 pill

Amid large scale vaccination in the country, the US government announced it will procure 1.7 million doses of antiviral treatment molnupiravir for coronavirus treatment from Merck.

US to procure 1.7 million courses of molnupiravir coronavirus pills

A US appeals court on Wednesday dealt a major blow to Merck & Co Inc as it upheld a ruling that threw out a $2.54 billion (£1.97 billion) jury verdict the drugmaker had won against Gilead Sciences Inc.

Merck loses bid to revive $2.54 billion patent verdict against Gilead

The chief executives resigned from a White House advisory panel on manufacturing after President Donald Trump's initial failure to explicitly condemn a white supremacist rally

After Merck, CEOs of Intel, Under Armour leave Trump panel over white nationalist rally

merck

Merck, News on Merck, stories on Merck, articles on Merck, Merck stories at Wion, Merck news, Merck latest news